Management of sleep disorders in fibromyalgia

Rheumatic Disease Clinics of North America

Volumn 28, Issue 2, 2002, Pages 353-365

  Moldofsky, Harvey ^a  

^a Sleep Disorders Clinic of the Centre for Sleep and Chronobiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BROMAZEPAM; CARBAMAZEPINE; CARBIDOPA; CODEINE; CYCLOBENZAPRINE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GABAPENTIN; GROWTH HORMONE; IBUPROFEN; LEVODOPA; MELATONIN; OPIATE; OXYCODONE; PERGOLIDE; PREGABALIN; ROPINIROLE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TALIPEXOLE; TENOXICAM; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; VALERIAN;

AROUSAL; BEHAVIOR THERAPY; CIRCADIAN RHYTHM; DRUG COST; DRUG TOLERANCE; ELECTROENCEPHALOGRAM; FIBROMYALGIA; FITNESS; HUMAN; HYPNOSIS; NEUROENDOCRINE DISEASE; NONREM SLEEP; NUTRITION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RESTLESSNESS; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP WAKING CYCLE;

FIBROMYALGIA; HUMAN; SLEEP DISORDERS; HUMANS;

EID: 0035990338     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(01)00012-6     Document Type: Review

References (60)

1. The relationship of the clinical features with psychological status in primary fibromyalgia
2. Musculoskeletal symptoms and nonREM sleep disturbance in patients with fibrositis syndrome and healthy subjects
3. Effects of selective Aslow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women
4. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation
5. The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor I
6. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome
7. Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia
8. Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome
9. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome
10. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome
11. Sleep intensity in fibromyalgia: Focus on the microstructure of the sleep process
12. Juvenile fibromyalgia. Clinical and polysomnographic aspects
13. Alpha sleep characteristics in fibromyalgia
14. The neuroscience and endocrinology of fibromyalgia
15. Comorbidity between myofascial pain of the masticatory muscles and fibromyalgia
16. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder
17. Periodic K-alpha sleep EEG activity and periodic leg movements during sleep: Comparisons of clinical features and sleep parameters
18. Sleep apnea in male patients with fibromyalgia syndrome
19. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
20. Sleep and periodic limb movement in sleep in juvenile fibromyalgia
21. Restless legs syndrome and leg cramps in fibromyalgia syndrome: A controlled study
22. Fibromyalgia syndrome: Overnight falls in arterial oxygen saturation
23. Musculoskeletal complaints and fibromyalgia in patients attending a respiratory sleep disorders clinic
24. Lack of association between fibromyalgia and sleep apnea syndrome
25. Periodic breathing during sleep in patients affected by fibromyalgia syndrome
26. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability
27. Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis
28. Quantification of sleepiness: A new approach
29. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia
30. EMG biofeedback training in fibromyalgia syndrome
31. Electroacupuncture in fibromyalgia: Results of a controlled trial
32. The C6-7 syndrome - Clinical features and treatment response
33. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia
34. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia
35. An exercise program in the treatment of fibromyalgia
36. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study
37. Comparison of amitriptyline, cyclobenzaprine and placebo in the treatment of fibromyalgia
38. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome
39. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia
40. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia
41. A double-blind placebo controlled trial of fluoxetine in fibromyalgia
42. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
43. Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial
44. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: A double-blind, placebo-controlled study
45. Zopiclone in the treatment of sleep abnormalities in fibromyalgia
46. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial
47. The effect of zolpidem in patients with fibromyalgia: A dose ranging, double blind, placebo controlled, modified crossover study
48. The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan
49. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome
50. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report
51. Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy
52. The effects of bright light treatment on the symptoms of fibromyalgia
53. Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia
54. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia
55. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of sleep medicine review
56. Restless legs syndrome improved by pramipexole: A double-blind randomized trial
57. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome
58. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables
59. Treatment of periodic leg movement disorder and restless leg syndrome with talipexole
60. Perspectives on the management of insomnia in patients with chronic respiratory disorders